Laboratory Corporation of America Holdings Profile Avatar - Palmy Investing

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two s…
Medical - Diagnostics & Research
US, Burlington [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 83% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio -24.89 0.88 1.17
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -15.78 12.14 14.42
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 2.04 94.64 92.76
Cash -81.33 1.18 6.32
Capex 19.21 -1.59 -1.97
Free Cash Flow -59.95 -1.95 4.86
Revenue 5.72 37.77 35.73
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 4.88 0.26 0.25
Operating Margin 36.92 0.10 0.08
ROA 38.05 0.01 < 0.005
ROE 35.00 0.03 -0.02
ROIC -3.84 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LH is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LH is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LH is permitted for members.
End of LH's Analysis
CIK: 920148 CUSIP: 50540R409 ISIN: US50540R4092 LEI: - UEI: -
Secondary Listings